Pharma Industry News
Printable Version   Email to a friend

Prednisolone Reduces Wheezing in Children with Colds

July 12, 2006

For children with wheezing associated with the common cold, prednisolone taken orally may reduce the risk of relapse, according to a new study.

However, prednisolone appears ineffective in alleviating wheezing associated with respiratory syncytial virus (RSV), another virus.

The study, by Tuomas Jartti and colleagues from Turku University Hospital, Finland, was published in the June issue of The Pediatric Infectious Disease Journal and reported by Reuters on July 4.

"Our results agree with previous studies showing that corticosteroids do not offer short- or long-term benefits in patients with RSV infection," wrote the authors.

Clinical Trial

The study included 78 preschool-age children hospitalized with a first or second episode of wheezing associated with rhinovirus (the virus that causes the common cold), or with RSV. The researchers compared the effectiveness of prednisolone (a total of 2 mg/kg per day, in three doses, over 3 days) with placebo.

Children who had both rhinovirus and RSV infections were excluded from the study.

The children with rhinovirus who received prednisolone experienced significantly fewer relapses during the following two months, as did children with high levels of eosinophils (a type of white blood cell involved in inflammation).

"Prednisolone decreased blood eosinophils, which was closely related to the rhinovirus infection," the authors reported.

Compared with children who had RSV infection, children with rhinovirus were more likely to have atopy (allergy) and had significantly higher levels of blood eosinophils on admission.

"We believe that our study supports the view that systemic corticosteroids in the dosages used are beneficial in the treatment of first or second time wheezing associated with rhinovirus infection and/or (elevated) blood eosinophils," said Dr Jartti in an interview with Reuters Health.

He added, "Recently, rhinovirus-induced early wheezing has been suggested as a new major risk factor for recurrent wheezing, and it has even been related to school age asthma."

Source:
Evaluation of the Efficacy of Prednisolone in Early Wheezing Induced by Rhinovirus or Respiratory Syncytial Virus. Tuomas Jartti, et al, The Pediatric Infectious Disease Journal, volume 25(6), pages 482-488, June 2006.
Steroid helpful in early wheezing due to colds, Reuters, July 4, 2006.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
August 14, 2008
Audience: Cardiologists, hospital risk managers [Posted 08/14/2008] Boston Scientific and FDA informed healthcare professionals...
August 12, 2008
Audience: Primary healthcare physicians, internists, other healthcare professionals[Posted 08/12/2008] FDA informed healthcare...
August 12, 2008
Audience: Pain management specialists, risk managers, other healthcare professionals, patients[UPDATED 08/12/2008] Watson...
August 8, 2008
Audience: Oncologists, other healthcare professionals[Posted 07/31/2008] FDA informed healthcare professionals of modifications...
More...
Latest Drug Information Updates

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

Navstel
Navstel is a balanced salt ophthalmic solution for use as an intraocular irrigation during surgical procedures involving perfusion of the eye.

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

More...